András Fittler

Dr. András Fittler

Faculty of Pharmacy Department of Pharmaceutics, University of Pécs
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2018 in Journal of Medical Internet Research
Verified
Journal Article
Open access
András FittlerAndrás Fittler
András Fittler
GVGyörgy Róbert Vida
György Róbert Vida
MKMátyás Káplár
Mátyás Káplár
LBLajos Botz
Lajos Botz
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: During the past two decades Internet has become an accepted way to purchase products and services. Apparently, buying medications online is no exception. Beside it’s benefits several patient safety risks are linked to the purchase of medicines outside the traditional supply chain. Although ten thousands of Internet pharmacies are accessible on the web, the actual size of the market is unknown. Further, limited data is available on the use of Internet pharmacies, the number and attitude of people obtaining medications and other health products from the Internet. Objective: The authors aimed to gather information on the frequency and attitudes of patients purchasing medications online in a nationally representative sample of outpatients. Attitudes towards main supply chain channels, perceived benefits and disadvantages influencing online medication purchase are evaluated. Methods: A cross sectional explorative study using a personally administered survey was conducted in a representative sample of Hungarian outpatients in 2018. Results: A total of 1055 outpatients completed the survey (response rate 77.2%). Mean age was 45 years and 43.2% reported to have chronic health conditions. Majority (82.7%) of the respondents were aware of that medications can be obtained online, but only 4.17% (n=44) used the Internet for medication purchase previously. Attitudes towards the different pharmaceutical supply chain retail channels showed significant differences (p<0,01), respondents accepted retail pharmacy units as the most appropriate source of medications while rejected Internet pharmacies. Respondents were asked to evaluate nine statements regarding the potential benefits and disadvantages about the online medicine purchase, and based on the computed relative attitude rate there is a weak still significant tendency toward rejection (p<0,01). Correspondence of demographic factors, internet usage behavior and prospective online drug purchase attitude was evaluated. Respondents who use the internet more and purchase goods online will more likely to buy medications online. Further, younger age and higher educational level will determine the medication purchase behavior. Conclusions: Reasonable number of patients will purchase medications on the Internet in the near future. As illegitimate actors dominate the global online pharmacy market, there is an increased risk of patients buying products from illegal actors. Consequently, improved patient-provider communication and promotion campaigns are needed to inform the public on the safe use of Internet pharmacies, as these initiatives can directly prevent patient safety threats.

10 September 2013 in Journal of Medical Internet Research
Verified
Journal Article
Open access
András FittlerAndrás Fittler
András Fittler
GBGergely Bősze
Gergely Bősze
LBLajos Botz
Lajos Botz
Evaluating Aspects of Online Medication Safety in Long-Term Follow-Up of 136 Internet Pharmacies: Illegal Rogue Online Pharmacies Flourish and Are Long-Lived

23 December 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
András FittlerAndrás Fittler
András Fittler
TATünde Ambrus
Tünde Ambrus
ASAnna Serefko
Anna Serefko
LSLenka Smejkalová
Lenka Smejkalová
AKAnna Kijewska
Anna Kijewska
MKMátyás Káplár
Mátyás Káplár
The COVID-19 pandemic accelerated the online purchase of goods and services in which today’s e-pharmacy is now an integral part of healthcare provisions in developed countries. The aim of our research was to assess the frequency and attitudes of European consumers purchasing medications online prior to and following the pandemic in the Visegrad Group countries (V4). An online cross-sectional study was conducted between May-August 2022. A 25-item questionnaire with single choice and 5-point Likert scale answers was used and implemented in Google forms and Pollfish. A sampling of 2087 responses was collected. A majority (92.8%) of the respondents were aware medicines can be purchased online, yet prefer traditional pharmacies (4.6 ± 0.8) and somewhat oppose the internet channel (2.8 ± 1.3). Following the outbreak of COVID-19 pandemic, respondents’ attitude towards purchasing consumer goods (3.65 ± 0.89) and medications (3.26 ± 0.91) online increased, however, the change regarding medications is significantly smaller (p < 0.01). A distinct increase in the frequency of buying medicines (from 49.16% to 55.48%) and health products (from 60.61% to 63.0%) online was measured since the breakout of the COVID-19 pandemic (p < 0.05). Despite the relatively high prevalence witnessed in previous purchases, our results highlight the trend in which 18.3% of participants will definitely purchase medications online while a proportionate 17.7% will not in the future. Although long-term post-COVID attitudes towards the internet pharmacy channel have modestly increased, in comparison to previously published research the frequency of purchasing medications online has significantly increased during the past years. As national legislation in V4 countries permit only non-prescription online sales, our findings are primarily applicable to countries with similar regulatory environment. The rapid global spread of the coronavirus has transitionally affected medicinal purchase behaviors, augmenting potential public health concerns related to online sourcing. Consequently, public awareness campaigns are needed to promote verified online pharmacies and prevent the utilization of illicit websites and the use of unregistered, substandard and falsified medicinal products.

25 October 2008 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
IGI. Gerlinger
I. Gerlinger
András FittlerAndrás Fittler
András Fittler
FFF. Fónai
F. Fónai
APA. Patzkó
A. Patzkó
AMA. Mayer
A. Mayer
LBL. Botz
L. Botz

András FittlerAndrás Fittler
András Fittler
LALatifat Adeniye
Latifat Adeniye
ZKZoltan Katz
Zoltan Katz
RBRichárd Bella
Richárd Bella
The COVID-19 pandemic and the related infodemic generated confusion and increased demand of various pharmaceuticals, ushering in the opportunity for illicit online vendors to fill a gap in the marketplace using potentially dangerous products. The aim of our study is to provide evidence regarding increased demand, online availability and consumer accessibility of ivermectin, an anthelmintic agent, without substantiated indications in reference to SARS-CoV-2. In our study, we combined infodemiology methodology aligned with search engine result assessment and website analytics to evaluate patient safety risks. Users’ Google queries regarding ivermectin were trending and peaked during the last week of November 2020 and March 2021. Consumers more likely found links leading directly or indirectly (via redirection) to illegal online retailers representing nearly half (53.3%) of search engine result links regarding the first three result pages in December 2020 and topped off at 73.3% by March 2021. Illicit medicine retailers outnumbered and outranked their legitimate counterparts and dominated the first search engine results page. A vast majority (77.7%) of the identified online pharmacies were characteristically rogue; more than half (55.5%) offered prescription-only products without a valid medical prescription. Our results illustrate connection between infodemic and its consequences on the illicit online pharmacy market

21 March 2024 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
AAAmir Reza Ashraf
Amir Reza Ashraf
TMTimothy Ken Mackey
Timothy Ken Mackey
András FittlerAndrás Fittler
András Fittler
Background: The online pharmacy market is growing, with legitimate online pharmacies offering advantages such as convenience and accessibility. However, this increased demand has attracted malicious actors into this space, leading to the proliferation of illegal vendors that use deceptive techniques to rank higher in search results and pose serious public health risks by dispensing substandard or falsified medicines. Search engine providers have started integrating generative artificial intelligence (AI) into search engine interfaces, which could revolutionize search by delivering more personalized results through a user-friendly experience. However, improper integration of these new technologies carries potential risks and could further exacerbate the risks posed by illicit online pharmacies by inadvertently directing users to illegal vendors. Objective: The role of generative AI integration in reshaping search engine results, particularly related to online pharmacies, has not yet been studied. Our objective was to identify, determine the prevalence of, and characterize illegal online pharmacy recommendations within the AI-generated search results and recommendations. Methods: We conducted a comparative assessment of AI-generated recommendations from Google’s Search Generative Experience (SGE) and Microsoft Bing’s Chat, focusing on popular and well-known medicines representing multiple therapeutic categories including controlled substances. Websites were individually examined to determine legitimacy, and known illegal vendors were identified by cross-referencing with the National Association of Boards of Pharmacy and LegitScript databases. Results: Of the 262 websites recommended in the AI-generated search results, 47.33% (124/262) belonged to active online pharmacies, with 31.29% (82/262) leading to legitimate ones. However, 19.04% (24/126) of Bing Chat’s and 13.23% (18/136) of Google SGE’s recommendations directed users to illegal vendors, including for controlled substances. The proportion of illegal pharmacies varied by drug and search engine. A significant difference was observed in the distribution of illegal websites between search engines. The prevalence of links leading to illegal online pharmacies selling prescription medications was significantly higher (P=.001) in Bing Chat (21/86, 24%) compared to Google SGE (6/92, 6%). Regarding the suggestions for controlled substances, suggestions generated by Google led to a significantly higher number of rogue sellers (12/44, 27%; P=.02) compared to Bing (3/40, 7%). Conclusions: While the integration of generative AI into search engines offers promising potential, it also poses significant risks. This is the first study to shed light on the vulnerabilities within these platforms while highlighting the potential public health implications associated with their inadvertent promotion of illegal pharmacies. We found a concerning proportion of AI-generated recommendations that led to illegal online pharmacies, which could not only potentially increase their traffic but also further exacerbate existing public health risks. Rigorous oversight and proper safeguards are urgently needed in generative search to mitigate consumer risks, making sure to actively guide users to verified pharmacies and prioritize legitimate sources while excluding illegal vendors from recommendations.